Deferoxamine mesylate
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 138-14-7
Synonym(S): Deferoxamine mesylate salt, DFOM, Deferoxamine methanesulfonate salt, Desferrioxamine mesylate salt
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 300 MG | 1166003-300-MG | In Stock | ₹ 40,756.13 |
1166003 - 300 MG
In Stock
Quantity
1
Base Price: ₹ 40,756.13
GST (18%): ₹ 7,336.103
Total Price: ₹ 48,092.233
grade
pharmaceutical primary standard
API family
deferoxamine
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
CS(O)(=O)=O.CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
InChI
1S/C25H48N6O8.CH4O3S/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;1-5(2,3)4/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);1H3,(H,2,3,4)
InChI key
IDDIJAWJANBQLJ-UHFFFAOYSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Desferrioxamine Mesilate, British Pharmacopoeia (BP) Reference Standard, MilliporeSigma™ Supelco™ | -- | ₹ 24,163.50 | ||
eMolecules Medchem Express / Deferoxamine (mesylate) / 100mg / 446273492 / HY-B0988 / / 138-14-7 / MFCD00058605 / 656.790 / C26H52N6O11S | -- | ₹ 7,860.48 | ||
Deferoxamine mesylate salt | -- | ₹ 16,107.60 | ||
Desferrioxamine mesilate | -- | ₹ 21,401.03 | ||
Deferoxamine Mesylate | -- | ₹ 21,465.98 | ||
Deferoxamine for system suitability | -- | ₹ 15,858.63 | ||
Deferoxamine Mesylate | -- | ₹ 18,010.00 | ||
138-14-7 | Deferoxamine mesylate | -- | ₹ 890.00 - ₹ 67,996.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Deferoxamine mesylate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
- Biochem/physiol Actions: An iron chelator used often in the studies of cell proliferation and apoptosis. Has been shown to have anti-proliferative effects on vascular smooth muscle cells in vitro and in vivo and to arrest cells in the G1 phase. Also reported to induce p53. Induces apoptosis in HL-60 cells by chelating iron. After 48 hrs treatment with 1μM deferoxamine, DNA fragmentation was apparent. Cells treated with 0.1 μM deferoxamine for as little as 24 hours were committed to apoptosis; by 48 hrs nuclear collapse was observed. In some studies it has been shown to have antioxidant properties and to protect cells against H2O2-induced damage.
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable